Neuroglympse utilizes FDA-cleared digital therapeutics for chronic insomnia and generalized anxiety disorder, backed by extensive clinical research.
The US FDA has granted clearance to DaylightRx—a digital therapeutic now available through Neuroglympse—for the treatment of generalized anxiety disorder (GAD).
Our solutions deliver evidence-based treatments through accessible digital platforms, enabling better access to mental healthcare.
Designed to meet patients where they are—at home, work, or anywhere care is needed.
Medically prescribed treatment solution
Delivers gold-standard CBT-I treatment
Recommended as the initial approach for chronic insomnia
Published in prestigious journals
Patients with significant insomnia reduction
Reduction in time to fall asleep
Reduction in nighttime wakefulness
No waitlists. No need to refer out. Patients can begin evidence-based treatment right away.
Over 75% of patients prefer non-drug treatments. SleepioRx addresses root causes, not just symptoms.
Easy, low-lift implementation enhances patient care without adding operational burden.
"SleepioRx gave me the tools to rebuild my sleep routine after years of insomnia. I finally feel rested again."
"It's science-based, interactive, and easy to follow. I wish I had found it sooner."
Clinically validated results
Regulated digital therapeutics
Meeting patients where they are
Integrate digital therapeutics into your care pathways
Enhance employee wellness programs
Improve outcomes while reducing costs
Expand your treatment options
SleepioRx is a prescription digital therapeutic for the treatment of chronic insomnia in adults aged 18 and over, available by order of a licensed healthcare provider. It is intended to be used as an adjunct to usual care.
DaylightRx is FDA-cleared for the treatment of generalized anxiety disorder (GAD) in adults. It should be used under the supervision of a healthcare provider.
Patients should read the full Indications for Use. DOC-3652 | Effective August 2024
© Neuroglympse 2025. All rights reserved. Serving employers, health plans, and care teams nationwide.
Speak with our healthcare solutions team
See our digital therapeutics in action
Receive detailed product specifications
Explore implementation options
Transforming mental healthcare through FDA-cleared digital therapeutics. Schedule your personalized demo today.
SleepioRx and DaylightRx are registered trademarks of BigHealth, Inc.
✅ Copyright © 2025 NeuroGlympse. All Rights Reserved.
If you are experiencing a medical emergency, please call 911 immediately.
This website is not monitored for urgent or emergency medical concerns. If you are in crisis or thinking about suicide, please call or text the 988 Suicide & Crisis Lifeline at 988, or chat online at 988lifeline.org. Help is available 24/7.
Neuroglympse: Transforming Mental Health with Digital Therapeutics